Innate immune responses of bat and human cells to filoviruses: Commonalities and distinctions

Journal of Virology

Volumn 91, Issue 8, 2017, Pages

  Kuzmin, Ivan V ^a,b   Schwarz, Toni M ^c   Ilinykh, Philipp A ^a,b   Jordan, Ingo ^d,f   Ksiazek, Thomas G ^a,b   Sachidanandam, Ravi ^c   Basler, Christopher F ^c,e   Bukreyev, Alexander ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d PROBIOGEN AG   (Germany)

^e GEORGIA STATE UNIVERSITY   (United States)

^f CureVac GmbH   (Germany)

Author keywords

Accidental host; Bat; Ebola virus; Immune evasion; Interferon inhibiting domain; Interferons; Marburg virus; Natural host

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON; INTERFERON; VIRAL PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE RESPONSE; EBOLAVIRUS; FILOVIRUS; GENETIC SIMILARITY; HOST RANGE; HOST RESISTANCE; HUMAN; HUMAN CELL; INNATE IMMUNITY; MARBURGVIRUS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; ROUSETTUS AEGYPTIACUS; SEQUENCE ANALYSIS; SPECIES DIFFERENCE; VIRUS CELL INTERACTION; VIRUS REPLICATION; ANIMAL; BAT; CELL LINE; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; PHYSIOLOGY; PROTEIN DOMAIN;

ANIMALS; CELL LINE; CHIROPTERA; EBOLAVIRUS; HUMANS; IMMUNE TOLERANCE; IMMUNITY, INNATE; INTERFERONS; MARBURGVIRUS; PROTEIN DOMAINS; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 85016556123     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02471-16     Document Type: Article

References (66)

1. Rougeron V, Feldmann H, Grard G, Becker S, Leroy EM. 2015. Ebola and Marburg haemorrhagic fever. J Clin Virol 64:111-119. https://doi.org/10.1016/j.jcv.2015.01.014.
2. Feldmann H, Geisbert TW. 2011. Ebola haemorrhagic fever. Lancet 377: 849-862. https://doi.org/10.1016/S0140-6736(10)60667-8.
3. Wong G, Kobinger GP, Qiu X. 2014. Characterization of host immune responses in Ebola virus infections. Expert Rev Clin Immunol 10:781-790. https://doi.org/10.1586/1744666X.2014.908705.
4. Messaoudi I, Amarasinghe GK, Basler CF. 2015. Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus. Nat Rev Microbiol 13:663-676. https://doi.org/10.1038/nrmicro3524.
5. Pestka S, Krause CD, Walter MR. 2004. Interferons, interferon-like cytokines, and their receptors. Immunol Rev 202:8-32. https://doi.org/10.1111/j.0105-2896.2004.00204.x.
6. Platanias LC. 2005. Mechanisms of type-I-and type-II-interferonmediated signalling. Nat Rev Immunol 5:375-386. https://doi.org/10.1038/nri1604.
7. Ben-Asouli Y, Banai Y, Pel-Or Y, Shir A, Kaempfer R. 2002. Human interferon-gamma mRNA autoregulates its translation through a pseudoknot that activates the interferon-inducible protein kinase PKR. Cell 108:221-232. https://doi.org/10.1016/S0092-8674(02)00616-5.
8. Rhein BA, Powers LS, Rogers K, Anantpadma M, Singh BK, Sakurai Y, Bair T, Miller-Hunt C, Sinn P, Davey RA, Monick MM, Maury W. 2015. Interferon-gamma inhibits Ebola virus infection. PLoS Pathog 11: e1005263. https://doi.org/10.1371/journal.ppat.1005263.
9. Barkhouse DA, Garcia SA, Bongiorno EK, Lebrun A, Faber M, Hooper DC. 2015. Expression of interferon gamma by a recombinant rabies virus strongly attenuates the pathogenicity of the virus via induction of type I interferon. J Virol 89:312-322. https://doi.org/10.1128/JVI.01572-14.
10. Iversen MB, Paludan SR. 2010. Mechanisms of type III interferon expression. J Interferon Cytokine Res 30:573-578. https://doi.org/10.1089/jir.2010.0063.
11. Wei H, Wang S, Chen Q, Chen Y, Chi X, Zhang L, Huang S, Gao GF, Chen JL. 2014. Suppression of interferon lambda signaling by SOCS-1 results in their excessive production during influenza virus infection. PLoS Pathog 10:e1003845. https://doi.org/10.1371/journal.ppat.1003845.
12. Sommereyns C, Paul S, Staeheli P, Michiels T. 2008. IFN-lambda (IFNlambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog 4:e1000017. https://doi.org/10.1371/journal.ppat.1000017.
13. Dunham EC, Banadyga L, Groseth A, Chiramel AI, Best SM, Ebihara H, Feldmann H, Hoenen T. 2015. Assessing the contribution of interferon antagonism to the virulence of West African Ebola viruses. Nat Commun 6:8000. https://doi.org/10.1038/ncomms9000.
14. Kuhn JH. 2008. Filoviruses, 1st ed. Springer, New York, NY.
15. Ilinykh PA, Lubaki NM, Widen SG, Renn LA, Theisen TC, Rabin RL, Wood TG, Bukreyev A. 2015. Different temporal effects of Ebola virus VP35 and VP24 proteins on global gene expression in human dendritic cells. J Virol 89:7567-7583. https://doi.org/10.1128/JVI.00924-15.
16. Lubaki NM, Ilinykh P, Pietzsch C, Tigabu B, Freiberg AN, Koup RA, Bukreyev A. 2013. The lack of maturation of Ebola virus-infected den-dritic cells results from the cooperative effect of at least two viral domains. J Virol 87:7471-7485. https://doi.org/10.1128/JVI.03316-12.
17. Prins KC, Delpeut S, Leung DW, Reynard O, Volchkova VA, Reid SP, Ramanan P, Cardenas WB, Amarasinghe GK, Volchkov VE, Basler CF. 2010 Mutations abrogating VP35 interaction with double-stranded RNA render Ebola virus avirulent in guinea pigs. J Virol 84:3004-3015. https://doi.org/10.1128/JVI.02459-09.
18. Albarino CG, Wiggleton Guerrero L, Spengler JR, Uebelhoer LS, Chakrabarti AK, Nichol ST, Towner JS. 2015. Recombinant Marburg viruses containing mutations in the IID region of VP35 prevent inhibition of host immune responses. Virology 476:85-91. https://doi.org/10.1016/j.virol.2014.12.002.
19. Hartman AL, Dover JE, Towner JS, Nichol ST. 2006. Reverse genetic generation of recombinant Zaire Ebola viruses containing disrupted IRF-3 inhibitory domains results in attenuated virus growth in vitro and higher levels of IRF-3 activation without inhibiting viral transcription or replication. J Virol 80:6430-6440. https://doi.org/10.1128/JVI.00044-06.
20. Lubaki NM, Younan P, Santos RI, Meyer M, Iampietro M, Koup RA, Bukreyev A. 2016. The Ebola interferon inhibiting domains attenuate and dysregulate cell-mediated immune responses. PLoS Pathog 12: e1006031. https://doi.org/10.1371/journal.ppat.1006031.
21. Mateo M, Reid SP, Leung LW, Basler CF, Volchkov VE. 2010. Ebolavirus VP24 binding to karyopherins is required for inhibition of interferon signaling. J Virol 84:1169-1175. https://doi.org/10.1128/JVI.01372-09.
22. Valmas C, Grosch MN, Schumann M, Olejnik J, Martinez O, Best SM, Krahling V, Basler CF, Muhlberger E. 2010. Marburg virus evades interferon responses by a mechanism distinct from Ebola virus. PLoS Pathog 6:e1000721. https://doi.org/10.1371/journal.ppat.1000721.
23. Luis AD, Hayman DT, O'Shea TJ, Cryan PM, Gilbert AT, Pulliam JR, Mills JN, Timonin ME, Willis CK, Cunningham AA, Fooks AR, Rupprecht CE, Wood JL, Webb CT. 2013. A comparison of bats and rodents as reservoirs of zoonotic viruses: are bats special? Proc Biol Sci 280:20122753. https://doi.org/10.1098/rspb.2012.2753.
24. Leroy EM, Kumulungui B, Pourrut X, Rouquet P, Hassanin A, Yaba P, Delicat A, Paweska JT, Gonzalez JP, Swanepoel R. 2005. Fruit bats as reservoirs of Ebola virus. Nature 438:575-576. https://doi.org/10.1038/438575a.
25. Towner JS, Pourrut X, Albariño CG, Nkogue CN, Bird BH, Grard G, Ksiazek TG, Gonzalez JP, Nichol ST, Leroy EM. 2007. Marburg virus infection detected in a common African bat. PLoS One 2:e764. https://doi.org/10.1371/journal.pone.0000764.
26. Towner JS, Amman BR, Sealy TK, Carroll SA, Comer JA, Kemp A, Swanepoel R, Paddock CD, Balinandi S, Khristova ML, Formenty PB, Albariño CG, Miller DM, Reed ZD, Kayiwa JT, Mills JN, Cannon DL, Greer PW, Byaruhanga E, Farnon EC, Atimnedi P, Okware S, Katongole-Mbidde E, Downing R, Tappero JW, Zaki SR, Ksiazek TG, Nichol ST, Rollin PE. 2009. Isolation of genetically diverse Marburg viruses from Egyptian fruit bats. PLoS Pathog 5:e1000536. https://doi.org/10.1371/journal.ppat.1000536.
27. Olival KJ, Hayman DT. 2014. Filoviruses in bats: current knowledge and future directions. Viruses 6:1759-1788. https://doi.org/10.3390/v6041759.
28. Swanepoel R, Leman PA, Burt FJ, Zachariades NA, Braack LE, Ksiazek TG, Rollin PE, Zaki SR, Peters CJ. 1996. Experimental inoculation of plants and animals with Ebola virus. Emerg Infect Dis 2:321-325. https://doi.org/10.3201/eid0204.960407.
29. Paweska JT, Storm N, Grobbelaar AA, Markotter W, Kemp A, Jansen van Vuren P. 2016. Experimental inoculation of Egyptian fruit bats (Rousettus aegyptiacus) with Ebola virus. Viruses 8:29. https://doi.org/10.3390/v8020029.
30. Paweska JT, Jansen van Vuren P, Fenton KA, Graves K, Grobbelaar AA, Moolla N, Leman P, Weyer J, Storm N, McCulloch SD, Scott TP, Markotter W, Odendaal L, Clift SJ, Geisbert TW, Hale MJ, Kemp A. 2015. Lack of Marburg virus transmission from experimentally infected to susceptible in-contact Egyptian fruit bats. J Infect Dis 212(Suppl 2):S109-S118. https://doi.org/10.1093/infdis/jiv132.
31. Paweska JT, Jansen van Vuren P, Masumu J, Leman PA, Grobbelaar AA, Birkhead M, Clift S, Swanepoel R, Kemp A. 2012. Virological and serological findings in Rousettus aegyptiacus experimentally inoculated with Vero cells-adapted Hogan strain of Marburg virus. PLoS One 7:e45479. https://doi.org/10.1371/journal.pone.0045479.
32. Amman BR, Jones ME, Sealy TK, Uebelhoer LS, Schuh AJ, Bird BH, Coleman-McCray JD, Martin BE, Nichol ST, Towner JS. 2015. Oral shedding of Marburg virus in experimentally infected Egyptian fruit bats (Rousettus aegyptiacus). J Wildl Dis 51:113-124. https://doi.org/10.7589/2014-08-198.
33. Middleton DJ, Morrissy CJ, van der Heide BM, Russell GM, Braun MA, Westbury HA, Halpin K, Daniels PW. 2007. Experimental Nipah virus infection in pteropid bats (Pteropus poliocephalus). J Comp Pathol 136:266-272. https://doi.org/10.1016/j.jcpa.2007.03.002.
34. Schountz T. 2014. Immunology of bats and their viruses: challenges and opportunities. Viruses 6:4880-4901. https://doi.org/10.3390/v6124880.
35. Baker ML, Zhou P. 2015. Bat immunology, p 327-348. In Wang L-F, Cowled C (ed), Bats and viruses: a new frontier of emerging infectious diseases. John Wiley & Sons, New York, NY.
36. Jones ME, Schuh AJ, Amman BR, Sealy TK, Zaki SR, Nichol ST, Towner JS. 2015 Experimental inoculation of Egyptian rousette bats (Rousettus aegyptiacus) with viruses of the Ebolavirus and Marburgvirus genera. Viruses 7:3420-3442. https://doi.org/10.3390/v7072779.
37. Ling PD, Warren MK, Vogel SN. 1985. Antagonistic effect of interferonbeta on the interferon-gamma-induced expression of Ia antigen in murine macrophages. J Immunol 135:1857-1863.
38. Taniguchi T, Takaoka A. 2001. A weak signal for strong responses: interferon-alpha/beta revisited. Nat Rev Mol Cell Biol 2:378-386. https://doi.org/10.1038/35073080.
39. Towner JS, Paragas J, Dover JE, Gupta M, Goldsmith CS, Huggins JW, Nichol ST. 2005. Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening. Virology 332:20-27. https://doi.org/10.1016/j.virol.2004.10.048.
40. Park MS, Shaw ML, Munoz-Jordan J, Cros JF, Nakaya T, Bouvier N, Palese P, Garcia-Sastre A, Basler CF. 2003. Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins. J Virol 77:1501-1511. https://doi.org/10.1128/JVI.77.2.1501-1511.2003.
41. Zhou P, Cowled C, Mansell A, Monaghan P, Green D, Wu L, Shi Z, Wang LF, Baker ML. 2014. IRF7 in the Australian black flying fox, Pteropus alecto: evidence for a unique expression pattern and functional conservation. PLoS One 9:e103875. https://doi.org/10.1371/journal.pone.0103875.
42. Zhou P, Cowled C, Todd S, Crameri G, Virtue ER, Marsh GA, Klein R, Shi Z, Wang LF, Baker ML. 2011. Type III IFNs in pteropid bats: differential expression patterns provide evidence for distinct roles in antiviral immunity. J Immunol 186:3138-3147. https://doi.org/10.4049/jimmunol.1003115.
43. Zhang G, Cowled C, Shi Z, Huang Z, Bishop-Lilly KA, Fang X, Wynne JW, Xiong Z, Baker ML, Zhao W, Tachedjian M, Zhu Y, Zhou P, Jiang X, Ng J, Yang L, Wu L, Xiao J, Feng Y, Chen Y, Sun X, Zhang Y, Marsh GA, Crameri G, Broder CC, Frey KG, Wang LF, Wang J. 2013. Comparative analysis of bat genomes provides insight into the evolution of flight and immunity. Science 339:456-460. https://doi.org/10.1126/science.1230835.
44. Baker ML, Schountz T, Wang LF. 2013. Antiviral immune responses of bats: a review. Zoonoses Public Health 60:104-116. https://doi.org/10.1111/j.1863-2378.2012.01528.x.
45. Zhou P, Tachedjian M, Wynne JW, Boyd V, Cui J, Smith I, Cowled C, Ng JH, Mok L, Michalski WP, Mendenhall IH, Tachedjian G, Wang LF, Baker ML. 2016. Contraction of the type I IFN locus and unusual constitutive expression of IFN-alpha in bats. Proc Natl Acad Sci U S A 113:2696-2701. https://doi.org/10.1073/pnas.1518240113.
46. Geisbert TW, Hensley LE, Larsen T, Young HA, Reed DS, Geisbert JB, Scott DP, Kagan E, Jahrling PB, Davis KJ. 2003. Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. Am J Pathol 163:2347-2370. https://doi.org/10.1016/S0002-9440(10)63591-2.
47. Kepler TB, Sample C, Hudak K, Roach J, Haines A, Walsh A, Ramsburg EA. 2010 Chiropteran types I and II interferon genes inferred from genome sequencing traces by a statistical gene-family assembler. BMC Genomics 11:444. https://doi.org/10.1186/1471-2164-11-444.
48. He G, He B, Racey PA, Cui J. 2010. Positive selection of the bat interferon alpha gene family. Biochem Genet 48:840-846. https://doi.org/10.1007/s10528-010-9365-9.
49. Feagins AR, Basler CF. 2015. Lloviu virus VP24 and VP35 proteins function as innate immune antagonists in human and bat cells. Virology 485:145-152. https://doi.org/10.1016/j.virol.2015.07.010.
50. Streicker DG, Turmelle AS, Vonhof MJ, Kuzmin IV, McCracken GF, Rupprecht CE. 2010. Host phylogeny constrains cross-species emergence and establishment of rabies virus in bats. Science 329:676-679. https://doi.org/10.1126/science.1188836.
51. Mortlock M, Kuzmin IV, Weyer J, Gilbert AT, Agwanda B, Rupprecht CE, Nel LH, Kearney T, Malekani JM, Markotter W. 2015. Novel paramyxoviruses in bats from sub-Saharan Africa, 2007-2012. Emerg Infect Dis 21:1840-1843. https://doi.org/10.3201/eid2110.140368.
52. Holzer M, Krahling V, Amman F, Barth E, Bernhart SH, Carmelo VA, Collatz M, Doose G, Eggenhofer F, Ewald J, Fallmann J, Feldhahn LM, Fricke M, Gebauer J, Gruber AJ, Hufsky F, Indrischek H, Kanton S, Linde J, Mostajo N, Ochsenreiter R, Riege K, Rivarola-Duarte L, Sahyoun AH, Saunders SJ, Seemann SE, Tanzer A, Vogel B, Wehner S, Wolfinger MT, Backofen R, Gorodkin J, Grosse I, Hofacker I, Hoffmann S, Kaleta C, Stadler PF, Becker S, Marz M. 2016. Differential transcriptional responses to Ebola and Marburg virus infection in bat and human cells. Sci Rep 6:34589. https://doi.org/10.1038/srep34589.
53. Matsumoto M, Tanaka N, Harada H, Kimura T, Yokochi T, Kitagawa M, Schindler C, Taniguchi T. 1999. Activation of the transcription factor ISGF3 by interferon-gamma. Biol Chem 380:699-703.
54. Levy DE, Lew DJ, Decker T, Kessler DS, Darnell JE, Jr. 1990. Synergistic interaction between interferon-alpha and interferon-gamma through induced synthesis of one subunit of the transcription factor ISGF3. EMBO J 9:1105-1111.
55. Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, Whitmore TE, Kuestner R, Garrigues U, Birks C, Roraback J, Ostrander C, Dong D, Shin J, Presnell S, Fox B, Haldeman B, Cooper E, Taft D, Gilbert T, Grant FJ, Tackett M, Krivan W, McKnight G, Clegg C, Foster D, Klucher KM. 2003. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 4:63-68. https://doi.org/10.1038/ni873.
56. Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, Shah NK, Langer JA, Sheikh F, Dickensheets H, Donnelly RP. 2003. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 4:69-77. https://doi.org/10.1038/ni875.
57. Kotenko SV. 2011. IFN-lambdas. Curr Opin Immunol 23:583-590. https://doi.org/10.1016/j.coi.2011.07.007.
58. Jordan I, Horn D, Oehmke S, Leendertz FH, Sandig V. 2009. Cell lines from the Egyptian fruit bat are permissive for modified vaccinia Ankara. Virus Res 145:54-62. https://doi.org/10.1016/j.virusres.2009.06.007.
59. Kuhl A, Hoffmann M, Muller MA, Munster VJ, Gnirss K, Kiene M, Tsegaye TS, Behrens G, Herrler G, Feldmann H, Drosten C, Pohlmann S. 2011. Comparative analysis of Ebola virus glycoprotein interactions with human and bat cells. J Infect Dis 204(Suppl 3):S840-S849. https://doi.org/10.1093/infdis/jir306.
60. Shaw G, Morse S, Ararat M, Graham FL. 2002. Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. FASEB J 16:869-871.
61. Bwaka MA, Bonnet MJ, Calain P, Colebunders R, De Roo A, Guimard Y, Katwiki KR, Kibadi K, Kipasa MA, Kuvula KJ, Mapanda BB, Massamba M, Mupapa KD, Muyembe-Tamfum JJ, Ndaberey E, Peters CJ, Rollin PE, Van den Enden E, Van den Enden E. 1999. Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. J Infect Dis 179(Suppl 1):S1-S7. https://doi.org/10.1086/514308.
62. Baize S, Pannetier D, Oestereich L, Rieger T, Koivogui L, Magassouba N, Soropogui B, Sow MS, Keita S, De Clerck H, Tiffany A, Dominguez G, Loua M, Traore A, Kolie M, Malano ER, Heleze E, Bocquin A, Mely S, Raoul H, Caro V, Cadar D, Gabriel M, Pahlmann M, Tappe D, Schmidt-Chanasit J, Impouma B, Diallo AK, Formenty P, Van Herp M, Gunther S. 2014. Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med 371: 1418-1425. https://doi.org/10.1056/NEJMoa1404505.
63. Albarino CG, Uebelhoer LS, Vincent JP, Khristova ML, Chakrabarti AK, McElroy A, Nichol ST, Towner JS. 2013. Development of a reverse genetics system to generate recombinant Marburg virus derived from a bat isolate. Virology 446:230-237. https://doi.org/10.1016/j.virol.2013.07.038.
64. Towner JS, Khristova ML, Sealy TK, Vincent MJ, Erickson BR, Bawiec DA, Hartman AL, Comer JA, Zaki SR, Ströher U, Gomes da Silva F, del Castillo F, Rollin PE, Ksiazek TG, Nichol ST. 2006. Marburgvirus genomics and association with a large hemorrhagic fever outbreak in Angola. J Virol 80:6497-6516. https://doi.org/10.1128/JVI.00069-06.
65. Lee AK, Kulcsar KA, Elliott O, Khiabanian H, Nagle ER, Jones ME, Amman BR, Sanchez-Lockhart M, Towner JS, Palacios G, Rabadan R. 2015. De novo transcriptome reconstruction and annotation of the Egyptian rousette bat. BMC Genomics 16:1033. https://doi.org/10.1186/s12864-015-2124-x.
66. Pfaffl MW, Horgan GW, Dempfle L. 2002. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30:e36. https://doi.org/10.1093/nar/30.9.e36.